Statistika
Kontakt Forum RSS
Poliklinika Harni
Nalazimo se na veoma pristupačnoj lokaciji u Maksimiru, Bukovačka 1. Maksimir je zbog svog položaja oduvijek utjecao na lice Zagreba, a novi stambeno-poslovni objekt na križanju Maksimirske i Bukovačke nastavlja pozitivnu tradiciju modernog arhitekturnog razvoja grada.

Statistika

Vezano
Vezani članci
Datum zadnje izmjene: 30. svibnja 2015.

RANDOMIZED CONTROLLED TRIALS 

(CONSORT Statement)

Authors of randomized control trials (RCT) must follow the guidelines presented in the CONSORT statement (http://www.consort-statement.org/), and submit a completed CONSORT manuscript checklist with their manuscript. Any reports of clinical trials must be registered by the time of submission. The word "random" or "randomized" should be in the title. The method of randomization, and allocation concealment must be specifically stated. Randomized trials must be submitted in a format consistent with the CONSORT statement, and include a CONSORT flow diagram as a figure (http://www.consort-statement.org/statement/figure1.htm). For reporting of harms and adverse outcomes, the extension of the CONSORT statement should be used and provided. For Cluster RCT, use (http://www.consort-statement.org/extensions?ContentWidgetId=554). For noninferiority and equivalence RCT, use the CONSORT Statement extension. For nonpharmacologic RCT, use the CONSORT extension. For herbal intervention RCT, use the CONSORT statement elaboration.

Experiment | Randomized experiment


FILE PDF DOWNLOAD:

CONSORT 1

CONSORT 2




SYSTEMATIC REVIEWS AND META-ANALYSES 

(PRISMA Guidelines)

Systematic reviews and meta-analyses must be reported according to PRISMA guidelines (http://prisma-statement.org). The manuscript must include a description of how authors searched for all the evidence, how they assessed the quality of that evidence, and how they combined the evidence. Assess risk of bias for trials, but avoid using summary quality scales and scores. A PRISMA checklist and flow diagram must be provided (http://www.equator-network.org). For meta-analyses of randomized, controlled trials, follow MOOSE reporting guidelines and provide the checklist (http://consort-statement.org/initiatives/moose/moosecheck.pdf).

FILE PDF DOWNLOAD:

PRISMA 1

PRISMA 2



COHORT, CASE-CONTROL, AND CROSS-SECTIONAL STUDIES 

(STROBE Statement)

Authors of reports of cohort, case-control, and cross-sectional studies of the prevalence, causes, mechanisms, diagnosis, course and prognosis, treatment, and prevention of disease (observational studies) must follow the guidelines presented in the STROBE statement (http://www.strobe-statement.org/Checklist.html), and submit a completed STROBE manuscript checklist for cohort, case-control, and cross-sectional studies with their manuscript. For reports of Molecular Epidemiology, use the STROBE-ME extension for Molecular Epidemiology. For reports of Genetic Risk Prediction, use the GRIPS Statement for Genetic Risk Prediction Studies. Genetic association studies must be reported according to STREGA guidelines. We encourage the registration of all observational studies on a WHO-compliant registry (see Lancet 2010; 375: 348).

Observational study
Survey methodology
Stratified sampling
Cluster sampling
Multivariate analysis
Regression analysis

FILE PDF DOWNLOAD:

STROBE 1

STROBE 2

STROBE 3

STROBE 4

STROBE 5

STROBE 6

STROBE 7

STROBE 8




COST-EFFECTIVENESS STUDIES 

(CHEERS statement)

Authors of cost-effectiveness studies must follow the guidelines presented in the CHEERS statement and checklist. (http://www.equator-network.org/wp-content/uploads/2013/09/CHEERS-Checklist-PDF.pdf)


STUDIES OF DIAGNOSTIC ACCURACY 

(STARD Guideline Statement)

Authors of studies of diagnostic accuracy must follow the guidelines presented in the in the STARD guideline statement (http://www.stard-statement.org/), and include a STARD flow diagram.
(http://www.equator-network.org).

FILE PDF DOWNLOAD:

STARD 1

STARD 2



Statistika